Brought to you by 
Start-up Pliant Therapeutics raises $45mm in Series A round
15 Sep 2017
Executive Summary
Newly formed Pliant Therapeutics Inc. raised $45mm in its Series A financing round with Third Rock Ventures. Proceeds will be used for overall pipeline development and to build an idiopathic pulmonary fibrosis (IPF) patient registry at University of California, San Francisco (UCSF) and an unidentified East Coast academic center in order to generate biomarker data that may inform drug discovery and clinical trial enrollment.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Start-up Pliant Therapeutics raises $45mm in Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice